FREE Account Opening + No Clearing Fees
Loading...
August 4, 2023 - August 8, 2023

Concord Biotech IPO Subscription Details

Concord Biotech IPO Subscription Status Live

Concord Biotech IPO subscribed 24.87 times. The public issue subscribed 3.78 times in the retail category, 67.67 times in QIB, and 16.99 times in the NII category by August 8, 2023 (Day 3).

Investor CategorySubscription (times)Shares OfferedShares Bid forTotal Amount (Rs Cr.)*
Qualified Institutions67.674,183,13028,30,64,54020,975.08
Non-Institutional Buyers16.993,137,3485,33,05,6803,949.95
  bNII (bids above ₹10L)19.302,091,5654,03,68,0002,991.27
  sNII (bids below ₹10L)12.371,045,7831,29,37,680958.68
Retail Investors3.787,320,4792,76,82,4802,051.27
Employees24.4810,0002,44,84018.14
Others[.]000
Total 24.8714,650,95736,42,97,54026,994.45

Total Application : 1,264,369 (3.45 times)

Disclaimer: *The total amount is calculated based on the final issue price or the price in the upper price range.


Concord Biotech IPO (Day-wise) Subscription Details (times)

DateQIBNIIRetailEMPTotal
Day 1
August 4, 2023
0.011.010.735.850.59
Day 2
August 7, 2023
1.615.222.2715.902.72
Day 3
August 8, 2023
67.6716.993.7824.4824.87

Concord Biotech IPO Shares Offered

Concord Biotech IPO is a public issue of 20,925,652 equity shares. The issue offers 7,320,479 shares to retail investors, 4,183,130 shares to qualified institutional buyers, and 3,137,348 shares to non-institutional investors.

CategoryShares OfferedAmount (Rs Cr) Size (%)
Anchor Investor6,274,695464.9529.99%
QIB4,183,130309.9719.99%
NII3,137,348232.4814.99%
    bNII (bids above ₹10L)2,091,565154.9810.00%
    sNII (bids below ₹10L)1,045,78377.495.00%
Retail7,320,479542.4534.98%
Employee10,0000.740.05%
Total20,925,6521,550.59100%

IPO Investor Categories

  • Qualified Institutional Buyers (QIB)

    Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.

  • Non-Institutional Investors(NII)

    Retail Individual Investors (HNI), NRIs, Companies, Trusts, etc who bid for shares worth more than Rs 2 lakhs are known as Non-institutional bidders (NII). Unlike QIB bidders, they do not need SEBI registration.

    NII category has two subcategories:

    1. sNII (bids below Rs 10L)

      The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category. This subcategory is also known as Small HNI (sHNI).

    2. bNII (bids above Rs 10L)

      The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory. This subcategory is also known as Big HNI (bHNI).

  • Retail Individual Investors(RII)

    The retail individual investor or NRIs who apply up to Rs 2 lakhs in an IPO are considered as RII reserved category.

  • Employee (EMP)

    A category of eligible employees who have a reserved quota in the IPO.

  • Others

    A category of eligible shareholders or other investors who have a reserved quota in the IPO.

What is the difference between RII, NII, QIB and Anchor Investor?

Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided here in is for informational purposes only and is provided by Chittorgarh.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. Chittorgarh.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. Chittorgarh.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. Chittorgarh.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.

Concord Biotech IPO Subscription FAQs

The Concord Biotech IPO is subscribed 24.87 by August 8, 2023.

Concord Biotech IPO Subscription

Investor CategorySubscription (times)
Qualified Institutional67.67
Non Institutional16.99
Retail Individual3.78
Employee Reservations24.48
Others[.]
Total Subscription24.87

Retail category of Concord Biotech IPO subscribed 3.78 times as of date August 8, 2023. The public issue closes on August 8, 2023 for bidding.

An investor can apply in Concord Biotech IPO online via bank (using ASBA) or the broker (using UPI). The Concord Biotech IPO shares are offered online only.

The Concord Biotech IPO is subscribed 24.87 by August 8, 2023.

The Concord Biotech IPO allotment status is expected on or around August 11, 2023. Visit Concord Biotech IPO allotment status to check.

The Concord Biotech IPO listing date is Friday, August 18, 2023. The equity share of Concord Biotech Limited will list on BSE, NSE.

Visit Concord Biotech IPO subscription status page for real-time bidding information about Concord Biotech IPO.

Concord Biotech IPO Timetable

IPO Opens OnAugust 4, 2023
IPO Closes OnAugust 8, 2023
Finalisation of Basis of AllotmentAugust 11, 2023
Initiation of RefundsAugust 14, 2023
Credit of Shares to Demat AccountAugust 17, 2023
IPO Listing DateAugust 18, 2023

2 Comments

2. SONMAYA     Link|August 8, 2023 3:18:08 PM
*Concord Biotech*

Approx break up applications : @3.00pm

HNI above 10L - ~25,233 (3.38x)

HNI 2-10L ~38,076(10.19x)

Retails - ~10,55,552(2.88x)
1. Krishan Chand     Link|August 8, 2023 2:16:20 PM
Seeing employees subscription hoping for postive listing.